NATCO PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Natco Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.22₹ -2.05
As on Dec 17, 2025, 4:01 PM IST
Natco Pharma Price Performance
Today's LowToday's High
₹913.05₹929.40
₹920.00
52 Weeks' Low52 Weeks' High
₹660.05₹1,490.00
₹920.00
Open Price
₹928.75
Prev. Close
₹922.05
Volume
60,570
Over the last 5 years, the share price of Natco Pharma has declined 0.46% CAGR. Over the past year, the corresponding return has been -35.85%.
Natco Pharma’s current P/E of 10.71x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Natco Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Natco Pharma | 6.05 | 12.13 | 7.29 | 5.43 | -35.85 | 18.76 | -0.46 |
| Sun Pharmaceutical Industries | 0.32 | 1.6 | 10.6 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.4 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.6 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.8 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6 | -17.85 | -10.3 | -20.7 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.4 |
| Alkem Laboratories | 0.29 | -1.9 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.5 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.3 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.7 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5 | -4.91 | 6.04 | 2.52 | -10.7 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20 | 26.95 |
Over the last one year, Natco Pharma has declined 35.85% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Natco Pharma has underperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
Natco Pharma Financials
Natco Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 896.84 | 910.38 |
| 10 | 913.77 | 905.92 |
| 20 | 884.96 | 892.05 |
| 50 | 846.36 | 870.17 |
| 100 | 869.1 | 874.75 |
| 200 | 865.25 | 918.96 |
Natco Pharma Share Holding Pattern
In the latest quarter, Natco Pharma saw a drop in promoter holding to 49.49%, while DII stake increased to 5.87%, FII holding fell to 14.09%, and public shareholding moved up to 30.56% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Natco Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 8,25,000 | 0.8 | 72.37 | |
| 6,03,569 | 1.53 | 52.95 | |
| 5,49,064 | 0.42 | 48.17 | |
| 72,000 | 1.07 | 6.32 | |
| 12,965 | 1.49 | 1.14 | |
| 6,109 | 1.49 | 0.54 | |
| 6,182 | 1.5 | 0.54 | |
| 5,676 | 1.45 | 0.5 | |
| 5,139 | 1.47 | 0.45 | |
| 3,747 | 1.46 | 0.33 |
* Excluding Index & Arbitrage Funds
Natco Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 02, 2025, 6:05 AM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| Nov 29, 2025, 3:20 PM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Nov 21, 2025, 9:42 PM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 20, 2025, 10:10 PM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 15, 2025, 5:21 PM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
About Natco Pharma
Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4094.50 Cr. and Equity Capital is Rs. 35.80 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressNATCO House, Road # 2, Banjara Hills, Hyderabad Telangana 500034
- Contact
Management
- Mr. V C NannapaneniChairman & Managing Director
- Mr. Rajeev NannapaneniVice Chairman & CEO
- Mr. P S R K PrasadDirector & Exe. VP (Corp. Engg. Services)
- Dr. D Linga RaoDirector & President (Tech. Affairs)
- Mr. D Vijaya BhaskarIndependent Director
- Mr. A D M ChavaliIndependent Director
- Dr. Kantipudi SumaIndependent Director
- Mr. Nitin JainIndependent Director
- Mr. Lakshminarayana BolisettyIndependent Director
FAQs on Natco Pharma Share Price
What is the share price of Natco Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Natco Pharma is ₹920.00 as on Dec 17, 2025.
What kind of stock is Natco Pharma?
The Natco Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Natco Pharma?
The market cap of Natco Pharma is ₹16,478.11 Cr as on Dec 17, 2025.
What are today's High and Low prices of Natco Pharma?
Today’s highest and lowest price of Natco Pharma are ₹929.40 and ₹913.05.
What are the 52 Week High and 52 Week Low of Natco Pharma?
The 52-week high/low is the highest and lowest price at which Natco Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Natco Pharma is ₹1,490.00 and 52-week low of Natco Pharma is ₹660.05 as on Dec 17, 2025.
How has the Natco Pharma performed historically in terms of returns?
The Natco Pharma has shown returns of -0.22% over the past day, 12.13% for the past month, 7.29% over 3 months, -35.85% over 1 year, 18.76% across 3 years, and -0.46% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Natco Pharma?
P/E ratio of and PB ratio of Natco Pharma are 10.71 and 2.17 on Dec 17, 2025. While the company gives a dividend yield of 0.65 per annum.
Natco Pharma News
✕
Market Pulse